Smith & Nephew

Court lifts injunction on sale of bipolar radio frequency products in U.S.

Published in Lab Law Weekly, June 10th, 2005

The United States Court of Appeals for the Federal Circuit announced its decision following Smith & Nephew's appeal of a District Court judgment.

The Appeals Court has lifted the injunction that prohibited Smith & Nephew from manufacturing or selling bipolar radio frequency products in the United States.

The Court of Appeals has also found that one out of 3 of ArthroCare's patents in this case is invalid. Separately, in recent re-examination proceedings, the United States Patent and Trademark Office (USPTO) rejected claims of the other 2 U.S. patents asserted against Smith & Nephew by ArthroCare.

Smith & Nephew is a medical...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2005-06-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry